India tightens watch on semaglutide supply after Interpol flags counterfeit batch

From the publisher

State drug regulators have been told to monitor distribution networks and crack down on suspect semaglutide batches after an Interpol alert linked to a counterfeit product detected in Austria.

The source's own excerpt, unedited